ArticleInvestigational new drugs2021

Rechallenge with previously administered epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer with leptomeningeal metastasis.

Taichi Miyawaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.